An approach to the treatment of spasticity.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D001418:Baclofen / Q000627:therapeutic use; D001927:Brain Diseases / Q000628:therapy; D003620:Dantrolene / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D006801:Humans; D008615:Mephenesin / Q000627:therapeutic use; D009129:Muscle Tonus; D009135:Muscular Diseases / Q000503:physiopathology; D010640:Phenothiazines / Q000627:therapeutic use; D012018:Reflex; D012597:Sclerosing Solutions / Q000627:therapeutic use; D013035:Spasm / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013122:Spinal Diseases / Q000628:therapy
D000317:Adrenergic alpha-Antagonists; D010640:Phenothiazines; D012597:Sclerosing Solutions; D008615:Mephenesin; D003620:Dantrolene; D001418:Baclofen; D003975:Diazepam